biotech · Glaucoma · Hepatocellular Carcinoma · AEON
AEON Biopharma
AEON Biopharma patent portfolio — 9 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- irvine, USA
- Employees
- 11
- Programs
- 9
- Drugs
- 8
- Patents
- 9
AEON Biopharma patents
9 pharmaceutical patents indexed for AEON Biopharma. 0 expire within 24 months.
AEON Biopharma has 9 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 11911455
HPV therapeutic nucleic acid vaccine
granted -
US 11826405
Neurotoxin compositions for use in treating headache
granted -
US 9901606
Euglena lysate composition
granted -
US 9274109
Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same
granted -
US 9201072
Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same
granted -
US 9149542
Microvesicles derived from cell protoplast and use thereof
granted -
US 9084830
Microvesicles derived from cell protoplast and use thereof
granted -
US 8969653
Extracellular vesicles derived from gram-positive bacteria, and use thereof
granted -
US 8691522
Composition comprising extracellular membrane vesicles derived from indoor air, and use thereof
granted
Frequently asked questions
How many patents does AEON Biopharma have?
9 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do AEON Biopharma patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.